Table 2.
Baseline characteristics of participants.
| characteristics | Group control (n=36) |
Group treatment (n=35) |
P-Value |
|---|---|---|---|
| Age(years) | 59.8±13.3 | 61.7±14.9 | 0.560 |
| Male (n,%) | 19(52.8%) | 16(45.7%) | 0.552 |
| APACHEII | 18.1±3.9 | 18.9±4.2 | 0.391 |
| TCM quantitative score of intestinal dysfunction | 10.5±3.0 | 9.8±2.7 | 0.901 |
| Delay between admission and inclusion(hours) | 12.8±5.1 | 11.9±4.8 | 0.896 |
| Type of infection (n, %) | |||
| Pneumonia | 16(44.4%) | 18(51.4%) | 0.556 |
| Peritonitis | 7(19.4%) | 7(20.0%) | 0.953 |
| CRBSI | 6(16.8%) | 4(11.4%) | 0.526 |
| Urinary tract infection | 7(19.4%) | 6(17.2%) | 0.802 |
| Dachenqi Decoction (as needed) | |||
| Patients administrated ≥ 1 dose (n, %) | 29(80.6%) | 26(74.3%) | 0.527 |
| The periods from administration of Dachenqi | 20.2±3.4 | 15.8±2.6 | 0.001 |
| Decoction to defecation (hours) | |||
| Days on MV | 8.3±2.1 | 7.7±2.0 | 0.260 |
| Length of stay in ICU(days) | 13.9±2.7 | 13.6±2.8 | 0.601 |
| 28-day mortality% (n) | 41.7%(15) | 37.1%(13) | 0.697 |
APACHE II: acute physiology and chronic health evaluation; CRBSI: catheter related bloodstream infection; MV: mechanical ventilation; ICU: intensive care unit.